Singapore launches first dedicated stem cell research hub for heart disease

Singapore has opened its first dedicated facility for stem cell research in cardiothoracic medicine, positioning the island nation as a regional leader in advanced cardiac treatments. The centre, established within the SingHealth Duke-NUS Academic Medicine Centre, represents a major investment in regenerative medicine research with potential applications across Southeast and South Asia.

The initiative is anchored by the inaugural Tong Ming Chuan Professorship in Cardiothoracic Surgery, underscoring the institution's commitment to attracting top-tier talent in the field. The professorship marks the first of its kind within the SingHealth Duke-NUS Academic Medicine Centre, a collaboration between Singapore's healthcare system and Duke University.

Stem cell research offers promising avenues for treating cardiac conditions that currently have limited therapeutic options. The dedicated centre will conduct research aimed at developing innovative approaches to heart disease management, potentially benefiting patients across Asia.

The establishment of this facility reflects Singapore's broader strategy to position itself as a biomedical research hub for the region, building on existing strengths in healthcare innovation and investment in medical research infrastructure.